In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 11 to 20 of 20

TitleConsultationTypeConsultation end date
Suspected Cancer: recognition and referral (update)Draft guidance consultationNICE guideline
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable [ID3843]Draft guidanceTechnology appraisal guidance
Statement of intent on NICE's approach to ongoing evaluations ahead of proposed changes to NICE's standard cost-effectiveness thresholdsNICE general consultationNICE general
Domestic AbuseDraft scope consultationNICE guideline
Lifileucel for previously treated unresectable or metastatic melanoma ID3863Draft guidanceTechnology appraisal guidance
Filgotinib for treating axial spondyloarthritis ID6594Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessmentDraft guidanceHealth technology evaluation
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma after 2 or more systemic treatments (review of TA677) [ID6325]Final draft guidanceTechnology appraisal guidance
Digital technologies to support self-management of asthma: early value assessmentDraft guidanceHealth technology evaluation
Rare diseasesQuality standard consultationQuality standard

Results per page

  1. 10
  2. 25
  3. 50
  4. All